[Effect of 25-HCC in a hypocalcemic patient with active metastases from an operated thyroid medullary tumor].
D002116:Calcitonin / Q000097:blood; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006996:Hypocalcemia / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D009362:Neoplasm Metastasis; D010710:Phosphates / Q000097:blood; D010758:Phosphorus / Q000378:metabolism; D011183:Postoperative Complications; D013964:Thyroid Neoplasms; D013965:Thyroidectomy; D013974:Thyroxine / Q000097:blood
D006887:Hydroxycholecalciferols; D010710:Phosphates; D010758:Phosphorus; D002116:Calcitonin; D013974:Thyroxine
Effet du 25-HCC chez un sujet hypocalcémique avec des métastases actives d'une tumeur médullaire thyroïdienne opérée.